Lacnotuzumab
N/A
Report date: 2025/06/05 20:00:13
Base Information
Drug NameLacnotuzumab
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[11]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[18]
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesWashington University School Of MedicineNovartis Pharma AgSeoul National University Hospital
Active IndicationsN/A
Inactive Indications +[11]
Other Information
ATC CodeN/A
Related LinksN/A